🔎 Trials Near Me

Hem › Major depression › Florida › Orlando

Kliniska studier för Major depression i Orlando, FL

19 studier för Major depression söker deltagare vid platser i och runt Orlando (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

RekryterarFas 3
  • Nova Psychiatry INC, Orlando
Ålder 18 till 74 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06559306

A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

RekryterarFas 2
  • Clinical Neuroscience Solutions Inc. - Orlando, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07621237

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

RekryterarFas 3
  • Accel Research Sites - Maitland, Maitland · 6 mi bort
Ålder 18 till 85 · Alla kön · Uppdaterad 25 sep. 2026 · NCT06793397

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

RekryterarFas 2
  • Seaport Investigator Site, Orlando
Ålder 18 till 65 · Alla kön · Uppdaterad 14 sep. 2026 · NCT07065240

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

RekryterarFas 2
  • Clinical Neuroscience Solutions, Inc., Orlando
Ålder 18 till 65 · Alla kön · Uppdaterad 14 sep. 2026 · NCT07284667

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

RekryterarFas 2
  • Draig Clinical Site, Orlando
  • Draig Clinical Site, Orlando
Ålder 18 till 75 · Alla kön · Uppdaterad 2 sep. 2026 · NCT07610473

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

RekryterarFas 2
  • Draig Clinical Site, Orlando
Ålder 18 till 75 · Alla kön · Uppdaterad 26 aug. 2026 · NCT07300969

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

RekryterarFas 3
  • Clinical Neuroscience Solutions, LLC (Orlando), Orlando
  • Charter Research, Orlando
  • K2 Medical Research (Maitland), Maitland · 6 mi bort
Ålder 18 till 74 · Alla kön · Uppdaterad 10 aug. 2026 · NCT07592689

NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RekryterarFas 3
  • Neurocrine Clinical Site, Maitland · 6 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 10 aug. 2026 · NCT06963021

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

RekryterarFas 3
  • Charter Research - Orlando, Orlando
  • K2 Medical Research - Maitland, Maitland · 6 mi bort
Ålder 18 till 75 · Alla kön · Uppdaterad 6 aug. 2026 · NCT07412756

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

RekryterarFas 3
  • Clinical Neuroscience Solutions, Inc., Orlando
Ålder 18 till 74 · Alla kön · Uppdaterad 3 aug. 2026 · NCT06775379

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

RekryterarFas 2
  • Clinical Neuroscience Solutions, Inc., Orlando
Ålder 18 till 64 · Alla kön · Uppdaterad 3 aug. 2026 · NCT06547489

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RekryterarFas 3
  • Neurocrine Clinical Site, Orlando
Ålder 18 och äldre · Alla kön · Uppdaterad 24 juli 2026 · NCT07196501

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RekryterarFas 3
  • Neurocrine Clinical Site, Maitland · 6 mi bort
  • Neurocrine Clinical Site, Maitland · 6 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 24 juli 2026 · NCT06966401

A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder

RekryterarFas 2
  • Clinical Neuroscience Solutions - Orlando - East South Street /ID# 277558, Orlando
Ålder 18 till 65 · Alla kön · Uppdaterad 15 juni 2026 · NCT07276997

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

RekryterarFas 3
  • Neurocrine Clinical Site, Maitland · 6 mi bort
Ålder 18 och äldre · Alla kön · Uppdaterad 29 okt. 2025 · NCT06786624

Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics

Rekryterar
  • AdventHealth Neuroscience Institute, Orlando
Ålder 60 och äldre · Alla kön · Uppdaterad 22 okt. 2025 · NCT05877885

Study of ALTO-300 in MDD

RekryterarFas 2
  • Site 159, Clermont · 24 mi bort
Ålder 18 till 70 · Alla kön · Uppdaterad 24 juli 2025 · NCT05922878

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

RekryterarFas 4
  • Clinical Research Site, Orlando
  • Clinical Research Site, Orlando
  • Clinical Research Site, Orlando
Ålder 18 till 65 · Alla kön · Uppdaterad 23 jan. 2025 · NCT06223880

Major depression-studier i andra städer

Andra studier i Orlando

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.